Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of GNC-077 for gastrointestinal cancers and other solid tumors is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Solid Tumor

Drugs mentioned

• GNC-077

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Gastrointestinal Tumors, Solid Tumor | Phase 1 | Status: NOT_YET_RECRUITING